Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

Journal of Immunology

Volumn 169, Issue 6, 2002, Pages 3447-3458

  Wedemeyer, Heiner ^a   He, Xiao Song ^a   Nascimbeni, Michelina ^a   Davis, Anthony R ^a   Greenberg, Harry B ^a   Hoofnagle, Jay H ^a   Liang, T Jake ^a   Alter, Harvey ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0037105567     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.6.3447     Document Type: Article

References (67)

1. Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
2. + T cells with viral clearance in acute hepatitis C
3. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
4. Analysis of a successful immune response against hepatitis C virus
5. Analysis of successful immune responses in persons infected with hepatitis C virus
6. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
7. Determinants of viral clearance and persistence during acute hepatitis C virus infection
8. Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C
9. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response, disease activity and viral load in patients with chronic hepatitis C virus infection
10. + memory T cells
11. Phenotypic analysis of antigen-specific T lymphocytes
12. + T cells produce antiviral cytokines but are impaired in cytolytic function
13. + T cells specific for EBV in healthy virus carriers
14. + T cells in peripheral blood and liver using peptide-MHC tetramers
15. + T lymphocytes after infection with hepatitis C virus
16. 10-Year follow-up after interferon-α therapy for chronic hepatitis C
17. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
18. Cell mediated immune response to the hepatitis C virus
19. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
20. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells
21. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution
22. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
23. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection
24. + T cells during the primary immune response to EpsteinBarr virus in vivo
25. A new look at T cells
26. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity
27. + T cells
28. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
29. CD27: Marker and mediator of T-cell activation?
30. Regulation of CD27 expression on subsets of mature T-lymphocytes
31. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor
32. Regulation of T cell function by NK cell receptors for classical MHC class I molecules
33. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
34. + T cells in chronic human immunodeficiency virus infection
35. + T cell responses
36. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study
37. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
38. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
39. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
40. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: Identification of multiple epitopes and characterization of patterns of cytokine release
41. + T-cell effector activity in HIV primary infection
42. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
43. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
44. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
45. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes
46. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant
47. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope
48. Is it a function of the secreted hepatitis Be antigen to induce immunologic tolerance in utero?
49. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection
50. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients
51. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence
52. Interaction between complement receptor gClqR and hepatitis C virus core protein inhibits T-lymphocyte proliferation
53. Association of hepatitis C virus in human sera with β-lipoprotein
54. - human T cells
55. Viral immune evasion due to persistence of activated T cells without effector function
56. + T cells during the chronic phase of infection
57. Functional analysis of T lymphocyte subsets in antiviral host defense
58. + cells but markedly decreased helper cell activity in mice lacking CD4
59. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses
60. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection
61. + T-cell response in acute hepatitis C
62. + cytotoxic T lymphocytes
63. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
64. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
65. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals
66. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus